CDTX
Price
$12.51
Change
-$0.17 (-1.34%)
Updated
May 3, 6:59 PM EST
5 days until earnings call
IKT
Price
$1.39
Change
+$0.05 (+3.73%)
Updated
May 3, 6:59 PM EST
Ad is loading...

Compare predictions CDTX vs IKT

Header iconCDTX vs IKT Comparison
Open Charts CDTX vs IKTBanner chart's image
Cidara Therapeutics
Price$12.51
Change-$0.17 (-1.34%)
Volume$32.53K
CapitalizationN/A
Inhibikase Therapeutics
Price$1.39
Change+$0.05 (+3.73%)
Volume$18.62K
CapitalizationN/A
View a ticker or compare two or three
CDTX vs IKT Comparison Chart

Loading...

CDTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IKTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CDTX vs. IKT commentary
May 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and IKT is a Hold.

COMPARISON
Comparison
May 04, 2024
Stock price -- (CDTX: $12.51 vs. IKT: $1.39)
Brand notoriety: CDTX and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 47% vs. IKT: 84%
Market capitalization -- CDTX: $57.07M vs. IKT: $9M
CDTX [@Biotechnology] is valued at $57.07M. IKT’s [@Biotechnology] market capitalization is $9M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileIKT’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • IKT’s FA Score: 1 green, 4 red.
According to our system of comparison, CDTX is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while IKT’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 6 bearish.
  • IKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IKT is a better buy in the short-term than CDTX.

Price Growth

CDTX (@Biotechnology) experienced а -0.95% price change this week, while IKT (@Biotechnology) price change was -18.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -3.94%, and the average quarterly price growth was +1240.85%.

Reported Earning Dates

CDTX is expected to report earnings on Aug 08, 2024.

IKT is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CDTX with price predictions.
OPEN
A.I.dvisor published
a Summary for IKT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CDTX($57.1M) has a higher market cap than IKT($9M). CDTX YTD gains are higher at: 1475.567 vs. IKT (9.449).
CDTXIKTCDTX / IKT
Capitalization57.1M9M634%
EBITDAN/AN/A-
Gain YTD1475.5679.44915,616%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt4.36MN/A-
FUNDAMENTALS RATINGS
CDTX: Fundamental Ratings
CDTX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
39
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDTXIKT
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
89%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
CDTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IKTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCC136.051.57
+1.17%
Boise Cascade Company
NTB35.370.25
+0.71%
Bank of NT Butterfield & Son Limited (The)
LL1.660.01
+0.61%
LL Flooring Holdings
AVD11.77N/A
N/A
American Vanguard Corp
BX117.99-1.00
-0.84%
Blackstone

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-1.34%
BPTSY - CDTX
92%
Closely correlated
N/A
IVVD - CDTX
36%
Loosely correlated
+2.11%
CPRX - CDTX
35%
Loosely correlated
-2.00%
CABA - CDTX
33%
Poorly correlated
-1.67%
TRAW - CDTX
30%
Poorly correlated
-0.87%
More

IKT and

Correlation & Price change

A.I.dvisor tells us that IKT and VERV have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IKT and VERV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+3.73%
VERV - IKT
33%
Poorly correlated
+4.23%
EVAX - IKT
30%
Poorly correlated
+1.54%
BPTH - IKT
30%
Poorly correlated
-1.88%
CYTK - IKT
25%
Poorly correlated
+1.45%
VAXX - IKT
24%
Poorly correlated
+35.41%
More